C4 Therapeutics Inc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| POINT72 ASSET MANAGEMENT, L.P. | 02/17/2026 | 9.44 M | $18.03 M | 100.00% | 13.01% |
| MORGAN STANLEY | 02/13/2026 | 8.98 M | $17.15 M | 80.64% | 12.38% |
| RA CAPITAL MANAGEMENT, L.P. | 02/17/2026 | 8.00 M | $15.28 M | 100.00% | 11.02% |
| BAIN CAPITAL LIFE SCIENCES INVESTORS, LLC | 02/17/2026 | 7.17 M | $13.70 M | 545.01% | 9.88% |
| LYNX1 CAPITAL MANAGEMENT LP | 02/17/2026 | 7.10 M | $13.56 M | 0.00% | 9.78% |
| VANGUARD GROUP INC | 01/29/2026 | 4.38 M | $8.37 M | 37.23% | 6.04% |
| WASATCH ADVISORS LP | 02/12/2026 | 4.34 M | $8.30 M | -10.46% | 5.99% |
| SOLEUS CAPITAL MANAGEMENT, L.P. | 02/12/2026 | 3.80 M | $7.27 M | -46.07% | 5.24% |
| BANK OF AMERICA CORP /DE/ | 02/17/2026 | 2.39 M | $4.56 M | 16.29% | 3.29% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 02/12/2026 | 1.99 M | $3.81 M | 5.10% | 2.75% |
| BLACKROCK, INC. | 02/12/2026 | 1.97 M | $3.76 M | 23.45% | 2.71% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/17/2026 | 1.78 M | $3.39 M | 244.52% | 2.45% |
| RENAISSANCE TECHNOLOGIES LLC | 02/12/2026 | 1.60 M | $3.06 M | 71.04% | 2.21% |
| TWO SIGMA INVESTMENTS, LP | 02/17/2026 | 1.51 M | $2.88 M | 80.85% | 2.08% |
| ORBIMED ADVISORS LLC | 02/17/2026 | 1.40 M | $2.68 M | -73.16% | 1.94% |
| MILLENNIUM MANAGEMENT LLC | 02/17/2026 | 1.19 M | $2.27 M | -38.53% | 1.64% |
| GOLDMAN SACHS GROUP INC | 02/10/2026 | 1.09 M | $2.08 M | 136.80% | 1.50% |
| TWO SIGMA ADVISERS, LP | 02/17/2026 | 1.07 M | $2.04 M | 39.98% | 1.47% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/09/2026 | 988.88 K | $1.89 M | 36.34% | 1.36% |
| JANE STREET GROUP, LLC | 02/12/2026 | 874.79 K | $1.67 M | 329.73% | 1.21% |
| WELLS FARGO & COMPANY/MN | 02/13/2026 | 809.26 K | $1.55 M | 4,236.87% | 1.12% |
| ACADIAN ASSET MANAGEMENT LLC | 02/10/2026 | 657.17 K | $1.25 M | 412.98% | 0.91% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 02/13/2026 | 449.43 K | $858.42 K | 28.19% | 0.62% |
| CITADEL ADVISORS LLC | 02/17/2026 | 447.81 K | $855.31 K | -6.99% | 0.62% |
| WALLEYE CAPITAL LLC | 02/13/2026 | 443.34 K | $846.78 K | 100.00% | 0.61% |
| 683 CAPITAL MANAGEMENT, LLC | 02/17/2026 | 400.00 K | $764.00 K | 100.00% | 0.55% |
| STATE STREET CORP | 02/13/2026 | 342.77 K | $654.70 K | 19.28% | 0.47% |
| DIMENSIONAL FUND ADVISORS LP | 02/12/2026 | 296.48 K | $566.47 K | -15.12% | 0.41% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 02/17/2026 | 290.23 K | $554.35 K | 150.26% | 0.40% |
| SUSQUEHANNA PORTFOLIO STRATEGIES, LLC | 02/17/2026 | 272.05 K | $519.62 K | 0.00% | 0.37% |
| INVESCO LTD. | 02/19/2026 | 268.35 K | $512.55 K | 39.90% | 0.37% |
| MARSHALL WACE, LLP | 02/13/2026 | 265.03 K | $506.20 K | 149.38% | 0.37% |
| FMR LLC | 02/17/2026 | 254.41 K | $485.92 K | 20.37% | 0.35% |
| LPL FINANCIAL LLC | 02/11/2026 | 243.31 K | $464.71 K | 21.09% | 0.34% |
| HENNION & WALSH ASSET MANAGEMENT, INC. | 01/14/2026 | 237.14 K | $452.93 K | 15.66% | 0.33% |
| BARCLAYS PLC | 02/13/2026 | 219.20 K | $418.68 K | 409.04% | 0.30% |
| ARROWMARK COLORADO HOLDINGS LLC | 02/17/2026 | 204.51 K | $390.61 K | 0.00% | 0.28% |
| NORTHERN TRUST CORP | 02/17/2026 | 166.21 K | $317.46 K | 20.16% | 0.23% |
| MAN GROUP PLC | 02/17/2026 | 156.10 K | $298.15 K | 72.91% | 0.22% |
| SQUAREPOINT OPS LLC | 02/13/2026 | 136.05 K | $259.86 K | 1,247.20% | 0.19% |
| QUADRATURE CAPITAL LTD | 02/17/2026 | 133.11 K | $254.24 K | 100.00% | 0.18% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 02/17/2026 | 131.10 K | $250.40 K | 64.08% | 0.18% |
| MARINER, LLC | 02/13/2026 | 128.05 K | $244.79 K | -0.15% | 0.18% |
| OMERS ADMINISTRATION CORP | 02/13/2026 | 117.70 K | $224.81 K | 100.00% | 0.16% |
| HUDSON BAY CAPITAL MANAGEMENT LP | 02/13/2026 | 111.55 K | $213.06 K | 100.00% | 0.15% |
| ATOM INVESTORS LP | 02/17/2026 | 104.96 K | $200.48 K | 100.00% | 0.14% |
| XTX TOPCO LTD | 02/17/2026 | 104.46 K | $199.52 K | -30.34% | 0.14% |
| GRAHAM CAPITAL MANAGEMENT, L.P. | 02/17/2026 | 102.20 K | $195.20 K | 151.55% | 0.14% |
| VIENNA POWSZECHNE TOWARZYSTWO EMERYTALNE S.A. VIENNA INSURANCE GROUP | 02/05/2026 | 85.00 K | $162.35 K | 0.00% | 0.12% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/17/2026 | 68.30 K | $130.45 K | 11.78% | 0.09% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
C4 Therapeutics Inc institutional Ownership - FAQ's
During the previous two years, 130 institutional investors and hedge funds held shares of C4 Therapeutics Inc. The most heavily invested institutionals were:
Point72 Asset Management, L.P.: 9.44 M
MORGAN STANLEY: 8.98 M
RA CAPITAL MANAGEMENT, L.P.: 8 M
Bain Capital Life Sciences Investors, LLC: 7.17 M
Lynx1 Capital Management LP: 7.1 M
VANGUARD GROUP INC: 4.38 M
109.98% of C4 Therapeutics Inc stock is owned by institutional investors.
Institutional investors have bought a total of 85.62 M shares in the last 24 months. This purchase volume represents approximately $271.42 M in transactions.